• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SORIN GROUP ITALIA S.R.L. CARBOSEAL VALSALVA ASCENDING AORTIC PROSTHESIS; HEART VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SORIN GROUP ITALIA S.R.L. CARBOSEAL VALSALVA ASCENDING AORTIC PROSTHESIS; HEART VALVE, MECHANICAL Back to Search Results
Model Number CP-027
Device Problems Leak/Splash (1354); Defective Component (2292)
Patient Problem Connective Tissue Disease (1786)
Event Date 10/20/2017
Event Type  Injury  
Manufacturer Narrative
A complete manufacturing and material records review for the device has been performed.The results confirmed that the device satisfied all material, visual and performance standards required at the time of manufacture and release.Device available but not yet received.
 
Event Description
(b)(6) 2017, a carboseal valsalva 27 mm valve graft was implanted for a bentall procedure.After all anastomoses were complete, it was found that the graft was leaking at the juncture between the valve and the graft.The physician placed a stitch in the area that the graft was leaking, but the leaking continued.After inspecting the graft, the physician believed the device to be defective and removed the product.A 30 mm tube graft and 23 mm top hat mechanical aortic valve were then implanted.The physician reported that, after removing the carboseal, a simple tube graft was sewn at the annular level and the top hat was sewn into the graft above the anastomosis.This was done to ensure the anastomosis was secure in the patient's fragile tissue.The patient was a marfan's patient with friable tissue.The surgery was delayed by 4 hours as a result of the event.
 
Manufacturer Narrative
The device was received for analysis on (b)(6) 2017.On (b)(6) 2017, a gross examination was conducted.The returned valve prosthesis was received with visible traces of collagen on the graft and also on the leaflets.The leaflets of the mechanical valve appeared to open/close normally.Two holes were observed on the graft, and evidence of the suturing stitches on the outflow ring were detected.(b)(4).
 
Manufacturer Narrative
Visual inspection of the returned valve confirmed the absence of non conformities and pre-existing defects.Two holes were observed on the graft surface, indicating the location of the anastamoses made during the implant procedure.One of these holes was formed by cutting the graft to release the anastamosis.Due to the size of the hole created during the explant procedure, it was not possible to conduct a permeability test, and the integrity of the graft could not be confirmed.Damage to the graft observed by microscopic evaluation suggests that the graft may have been punctured by the suturing needle during implant.However, this damage may also have been created during an attempt to repair the reported leakage.Given that a permeability test could not be performed, the integrity of the conduit and valve could not be confirmed, and it is was not possible to identify the root cause of the event.It is possible that damage to the graft occurred during the implant procedure; however, the possibility that this damage occurred during attempted repair of the reported leak cannot be excluded.It should also be noted that blood leakage through or around the cuff of valved conduits is a phenomenon that is occasionally observed during the implant of conduits made by most, if not all, manufacturers.Given this, it is also not possible to exclude the possibility that the observed leakage was attributable to blood seepage in this manner.Ultimately, the root cause of the event could not be determined, as limited investigation was possible given the condition of the returned device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARBOSEAL VALSALVA ASCENDING AORTIC PROSTHESIS
Type of Device
HEART VALVE, MECHANICAL
Manufacturer (Section D)
SORIN GROUP ITALIA S.R.L.
strada crescentino snc
saluggia 13040
IT  13040
Manufacturer (Section G)
SORIN GROUP ITALIA S.R.L.
strada crescentino snc
saluggia
Manufacturer Contact
francesca crovato
5005 north fraser way
burnaby, bc 
MDR Report Key7047621
MDR Text Key92588107
Report Number3005687633-2017-00116
Device Sequence Number1
Product Code LWQ
UDI-Device Identifier08022057013569
UDI-Public(01)08022057013569(240)CP-027(17)200901
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
P900060
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 01/05/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/20/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date09/09/2020
Device Model NumberCP-027
Device Catalogue NumberCP-027
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/21/2017
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/21/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/21/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-